Blood glucose monitoring and any necessary adjustments to insulin or sulfonylurea doses should be managed under the supervision of the trial team or treating clinician
Allosteric (off active site) activators were reported in the literature as early as the mid-2000s, but they had poor potency, poor pharmacokinetics, species-selective activity (human but not rodent), and none made it close to the clinic
Proper dosing, monitoring, and medical oversight are essential for both the safety and effectiveness of semaglutide injections
GLP-1 receptors are distributed throughout the body, including in the pancreas, gastrointestinal tract, heart, kidneys, and notably, the central nervous system
Now, that may be easier said than done
Hes also had a history of chronic lower gastrointestinal (GI) tract issues